Takasaki Kenji, Enatsu Kaori, Kumagami Hidetaka, Takahashi Haruo
Department of Otolaryngology, Head and Neck Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Int J Otolaryngol. 2009;2009:495186. doi: 10.1155/2009/495186. Epub 2009 Nov 25.
Aims. To measure blood and tissue concentrations of the H1-receptor antagonist, bepotastine besilate (BB). Methods. Participants included 14 men and six women, whose age ranged from 13 to 76 years, with chronic rhinosinusitis, who underwent endoscopic sinus surgery at our university hospital. Among them, 10 participants had allergic rhinitis (AR) (Group I), and others did not have AR (Group II). Nasal mucosa and blood were collected 55 to 130 minutes after oral administration of BB 10 mg. Concentrations of the agent in the serum and nasal mucosa were measured by high-performance liquid chromatography. Results. Concentrations of BB of the serum in Group I and II were 98 +/- 32 ng/mL and 112 +/- 39 ng/mL. Those of the nasal mucosa tissue in Groups I and II were 101 +/- 36 ng/g and 132 +/- 44 ng/g. There was no significant difference in the values of concentration of BB between the serum and the nasal mucosa in either Group I or II (P = .757 and P = .2662, resp., Paired t-test). Conclusion. This preliminary study is considered the first report on the concentration of H1-receptor antagonists in nasal mucosa. The prompt absorption and transition to the nasal mucosa of BB seems to have an effect on allergic rhinitis.
目的。测量H1受体拮抗剂苄丝特明(BB)的血液和组织浓度。方法。参与者包括14名男性和6名女性,年龄在13至76岁之间,患有慢性鼻窦炎,在我们大学医院接受了鼻内镜鼻窦手术。其中,10名参与者患有过敏性鼻炎(AR)(第一组),其他参与者没有AR(第二组)。口服10毫克BB后55至130分钟采集鼻黏膜和血液。通过高效液相色谱法测量血清和鼻黏膜中该药物的浓度。结果。第一组和第二组血清中BB的浓度分别为98±32纳克/毫升和112±39纳克/毫升。第一组和第二组鼻黏膜组织中的浓度分别为101±36纳克/克和132±44纳克/克。第一组或第二组血清和鼻黏膜中BB浓度值均无显著差异(分别为P = 0.757和P = 0.2662,配对t检验)。结论。这项初步研究被认为是关于鼻黏膜中H1受体拮抗剂浓度的首次报告。BB迅速吸收并转移至鼻黏膜似乎对过敏性鼻炎有影响。